Iron does not directly raise or lower potassium through a single, clean metabolic pathway the way, say, insulin or aldosterone does. But the two minerals are connected through several indirect routes, and disruptions in iron status can nudge potassium levels in clinically meaningful ways. These connections show up across a range of situations: iron-deficiency anemia, iron overload conditions, hemolytic episodes, iron chelation therapy, and even the unusual eating behaviors that severe iron deficiency can trigger. The relationship is real, but it is scattered across multiple mechanisms rather than one tidy cause-and-effect chain.
Iron-Deficiency Anemia and Higher Serum Potassium
One of the more straightforward links between iron and potassium comes from studies of people with anemia. A study comparing electrolyte panels in anemic versus non-anemic patients found that potassium levels were measurably higher in the anemic group, averaging about 4.37 meq/L compared to 4.09 meq/L in people without anemia.1Cureus. Evaluation of Serum Electrolyte Levels in Patients With Anemia Both values fall within the normal range for most labs, but the gap was statistically significant. The likely explanation involves shifts in how cells handle electrolytes when they are chronically starved of oxygen. Red blood cells that are smaller and fewer in number change the dynamics of potassium trafficking between the inside and outside of cells.
This does not mean that iron deficiency causes dangerous hyperkalemia on its own. For most people with mild to moderate anemia, the potassium bump stays within normal bounds and causes no symptoms. But for someone who already has borderline-high potassium for other reasons, such as kidney disease or certain medications, even a small additional push could matter.
What Happens When Red Blood Cells Break Apart
Red blood cells are packed with potassium. The concentration inside them is far higher than in the surrounding blood. When red blood cells rupture, a process called hemolysis, that potassium floods into the bloodstream. Several iron-related conditions cause hemolysis: sickle cell disease, thalassemia, autoimmune hemolytic anemias, and transfusion reactions. A healthy body deals with this quickly. The kidneys ramp up potassium excretion, and the body’s normal regulatory systems bring levels back down before they become dangerous.2Clinical Chemistry. Normal Potassium in the Presence of Gross Hemolysis
This distinction is worth understanding because it trips up lab work all the time. If a blood sample gets mishandled and the red blood cells in the tube burst, the potassium reading comes back falsely high, sometimes dramatically so. Clinicians call this a spurious or pseudohyperkalemia result. It is one of the most common reasons for a repeated blood draw. But when hemolysis happens inside the body, the potassium surge is real, just typically short-lived because the kidneys compensate. The exception is in people whose kidneys are impaired, where even temporary potassium spikes from hemolysis can become clinically significant.
Iron Overload and the Sodium-Potassium Pump
Every cell in your body uses a protein called the sodium-potassium pump to keep potassium concentrations high inside the cell and low outside. This pump is the reason the potassium in your blood stays in a tight range even though there is far more potassium locked inside your cells. Iron overload appears to alter how this pump behaves, and the effects are not straightforward.
In people with chronic iron overload, a study of red blood cell membranes found that the pump’s activity was roughly three times higher than in healthy controls.3PLOS ONE. Effects of Iron Overload on the Activity of Na,K-ATPase and Lipid Profile of the Human Erythrocyte Membrane That sounds counterintuitive: if the pump is more active, it should be pulling more potassium into cells and keeping blood levels low. But the picture is more complex. Laboratory experiments exposing the pump to iron in a controlled setting found that its response depends on which structural state the pump is in and which version of the pump protein is present. In some configurations, iron activated the pump; in others, it inhibited it.4Biochimica et Biophysica Acta (BBA) – Biomembranes. Effect of Fe3+ on Na,K-ATPase: Unexpected activation of ATP hydrolysis
What this means in practical terms is still being worked out. The research is clear that excess iron interacts directly with one of the most fundamental electrolyte-handling proteins in the body, but whether that interaction produces a net increase or decrease in blood potassium in a living person depends on the tissue, the degree of overload, and other variables. This is one of those areas where the basic science is ahead of the clinical science: researchers can see the mechanism moving, but predicting the outcome for a given patient remains difficult.
Iron Overload and Heart Rhythm
The connection between iron overload and cardiac problems is well established, particularly in people who have received many blood transfusions. One of the ways excess iron affects the heart is by altering how potassium channels in heart muscle cells behave. Animal studies using iron-overloaded heart cells showed an increase in one of the potassium currents responsible for resetting the electrical signal between heartbeats.5Wiley Online Library. Iron overload and arrhythmias: Influence of confounding factors The result was a shorter electrical signal and changes to how the heart’s rhythm is generated.
This does not mean iron overload causes whole-body potassium levels to spike or crash. The potassium channel changes happen locally, inside individual heart cells, and they reflect how those cells respond to iron damage rather than a systemic shift in the body’s potassium balance. But it does mean that for people with iron overload, the heart’s sensitivity to potassium is altered. An abnormally high or low blood potassium level that a healthy heart might tolerate could provoke an arrhythmia in an iron-loaded heart. Cardiologists monitoring transfusion-dependent patients watch electrolytes closely for this reason.
Iron Deficiency, Pica, and Severe Potassium Loss
One of the stranger connections between iron and potassium runs through behavior rather than biochemistry. Severe iron deficiency often triggers pica, an intense craving to eat non-food items. Common pica targets include ice, starch, clay, and soil. Clay ingestion, sometimes called geophagia, is especially relevant to potassium because clay minerals bind potassium in the gut and prevent its absorption.
A case report described an elderly woman who developed such severe potassium depletion from clay ingestion that she became paralyzed, a condition called hypokalemic paralysis. Her underlying iron deficiency had driven the pica behavior, and the clay she was eating was draining her body of potassium. Treatment with both potassium supplementation and correction of the iron deficiency resolved her symptoms.6International Journal of Research in Medical Sciences. Clay ingestion induced hypokalemic paralysis: a rare case report in an elderly female with severe iron deficiency anemia
This pathway is indirect, and it only applies to people who develop pica. But it illustrates an important point: iron deficiency can cause potassium problems through routes that no one would predict from looking at a biochemistry textbook. The iron deficiency drives the craving, the craving drives the consumption, and the consumption drains the potassium. Correcting just the potassium without addressing the iron deficiency would likely result in a relapse.
Iron Chelation Drugs and Kidney Tubule Effects
People with iron overload from repeated transfusions often take chelation drugs to pull excess iron out of their bodies. These drugs work, but some of them affect the kidneys in ways that alter electrolyte handling. Deferasirox, one of the most commonly used oral iron chelators, has been linked to changes in how the kidney tubules process electrolytes.
In a study of children with beta-thalassemia receiving deferasirox, serum potassium levels rose after treatment, while calcium, magnesium, and uric acid levels dropped.7PubMed. A prospective study of tubular dysfunction in pediatric patients with Beta thalassemia major receiving deferasirox The mechanism appears to involve the drug’s effects on the kidney’s proximal tubules, which are responsible for reabsorbing or excreting a wide range of substances. When those tubules are stressed or mildly damaged, their handling of electrolytes shifts in sometimes unpredictable ways.
A separate case highlighted another angle: a teenager with thalassemia on high-dose deferasirox developed a type of metabolic acidosis, with her potassium sitting at 3.6 mM, the low end of normal.8PubMed. Hyperchloraemic metabolic acidosis induced by the iron chelator deferasirox: a case report and review of the literature Metabolic acidosis itself can push potassium out of cells and into the blood initially, but over time, chronic acidosis leads to potassium wasting through the kidneys. The direction potassium moves depends on the type and duration of the acid-base disturbance. For patients on long-term iron chelation, regular monitoring of both kidney function and electrolytes is standard practice precisely because these shifts can creep up gradually.
Does Iron Overload Damage the Adrenal Glands Enough to Affect Potassium?
Aldosterone, a hormone produced by the adrenal glands, is the body’s primary regulator of potassium excretion. When aldosterone drops, potassium rises. Because iron overload conditions like hemochromatosis are notorious for damaging hormone-producing glands, it seems reasonable to worry that the adrenals might be affected, and potassium regulation along with them.
The evidence on this is somewhat reassuring. A study specifically examining mineralocorticoid function in patients with severe hemochromatosis found that primary aldosterone deficiency was not present. One patient out of the group had a combined deficiency in both renin and aldosterone, but this was an isolated case accompanied by other hormonal problems.9PubMed. Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis In other words, the adrenal glands’ potassium-regulating machinery seems to hold up reasonably well even under significant iron loading, at least compared to how badly iron overload can damage the pancreas, liver, or pituitary gland.
This does not mean it never happens. Iron overload is a slow, cumulative process, and individual organs vary in their vulnerability. But the concern that hemochromatosis routinely causes hyperkalemia through aldosterone deficiency appears to be overstated based on the available evidence.
Intravenous Iron Infusions and Mineral Shifts
Intravenous iron infusions have become a mainstay for treating iron deficiency when oral supplements are not enough or not tolerated. These infusions are generally safe, but certain formulations trigger a cascade that affects mineral handling. The most studied example involves a hormone called FGF23. Some IV iron preparations rapidly increase levels of active FGF23, which in turn causes the kidneys to dump phosphate into the urine.10Journal of Clinical Investigation. Randomized trial of intravenous iron-induced hypophosphatemia – Section: Discussion
The primary electrolyte target of this FGF23 surge is phosphate rather than potassium, so the direct risk is low phosphate levels, not potassium abnormalities. However, the FGF23 pathway does interact with the kidneys’ broader electrolyte handling, and large swings in one mineral can ripple through the system. Severe phosphate depletion, for instance, can cause muscle weakness and fatigue that clinically resembles the effects of low potassium, making it important to check both electrolytes when someone develops symptoms after an iron infusion.
Among the various IV iron products, ferric carboxymaltose has been the most strongly linked to FGF23-driven phosphate losses. Other formulations appear to cause the effect less frequently or to a lesser degree. If you are receiving IV iron and your doctor checks a full electrolyte panel afterward, this is part of the reason why.
When Iron Supplements and Potassium-Rich Diets Overlap
Many people taking iron supplements are also managing conditions that affect potassium, and the dietary advice for these conditions can pull in different directions. Iron absorption is enhanced by vitamin C, found abundantly in citrus fruits and tomatoes. Potassium is abundant in many of the same foods, plus bananas, potatoes, and leafy greens. For someone with normal kidney function, eating a potassium-rich diet while supplementing iron is generally a non-issue because healthy kidneys adjust potassium excretion to match intake very efficiently.
The situation gets more complicated for people with kidney disease. Impaired kidneys lose the ability to shed excess potassium quickly, and these patients are often told to limit high-potassium foods. If they are also iron deficient, which is common in chronic kidney disease, the dietary restrictions meant to control potassium can inadvertently limit iron-rich foods as well, since many plant-based iron sources (spinach, beans, dried fruit) are also high in potassium. Clinicians managing these patients often rely on IV iron or carefully dosed oral supplements rather than dietary strategies alone, specifically to sidestep this overlap.
Practical Implications for Lab Work
If you have an iron disorder and your potassium comes back slightly abnormal on a blood test, the two may be connected through any of the routes described above, or the result may be an artifact. Hemolysis during the blood draw itself is the most common cause of a falsely elevated potassium reading, and people with anemia or fragile red blood cells are more prone to having their samples hemolyze in the tube.2Clinical Chemistry. Normal Potassium in the Presence of Gross Hemolysis A single mildly elevated potassium value in someone with known hemolytic anemia should prompt a repeat draw with careful technique before anyone panics.
For people on iron chelation therapy, electrolyte monitoring is built into the treatment protocol because the kidney effects are well recognized. For those with hemochromatosis being treated with phlebotomy, routine potassium checks are less standard because the aldosterone system typically remains intact. And for the average person taking an over-the-counter iron supplement for mild deficiency, worrying about potassium shifts is not necessary. The effects described here emerge at the extremes of iron status: deep deficiency, significant overload, or aggressive pharmacological intervention. Ordinary iron supplementation in an otherwise healthy person is not going to meaningfully change your potassium level.